Company Profile
TG Therapeutics Stock Price, News & Analysis
- Ticker:
- TGTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, TG Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
53.94 USD (-0.85%)
Close
Last updated: June 23, 2026 at 00:00
8.26B USD
Market cap
Why the stock is moving
TGTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
TG Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, TG Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
TG Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, TG Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
TG Therapeutics to Participate in the Goldman Sachs 47th Annual Healthcare Conference
Source: TG Therapeutics
- 04
- 05
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
Source: TG Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of TG Therapeutics (TGTX)?
TG Therapeutics (TGTX) most recently closed at 53.94 USD, a -0.85% move versus the previous session.
What is the market cap of TG Therapeutics (TGTX)?
TG Therapeutics currently has a market capitalization of 8.26B USD on BioPharmSignal.
What does TG Therapeutics do?
TG Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TGTX stock listed?
TG Therapeutics (TGTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, TG Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Therapeutics?
TG Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is TG Therapeutics targeting with Therapeutics?
TG Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.